LILRB2 and metastatic malignant neoplasm in the lymph nodes: Upregulated ILT2 and ILT4 expression has been associated with lymph node metastasis, shorter overall survival and a lower number of tumor-infiltrating lymphoid cells [15,16,19,20,21,22,23,24].